Arbutus Biopharma Corporation Common Stock

ABUS Real Time Price USD
N/A
N/A
N/A
...
Overview
Financials
Insiders
Institutions
Government

Chart provided by TradingView

Income
Balance Sheet
Cash Flow
ABUS Income Statement
ABUS Balance Sheet
ABUS Cash Flow
Congress Trading

Recent trades of ABUS by members of U.S. Congress

Quiver Logo

No Congress Trading data for this ticker

Congress Trading Dashboard
ABUS Stock Insider Trading Activity
Name
Type
Shares
Price
Shares Held
Date
Reported
ABUS Stock Institutional Owners
Investor
Shares
Change in Shares
Market Value
Date
Reported
ABUS Derivatives Institutional Owners
Investor
Type
Shares
Change in Shares
Market Value
Date
Reported
Whale Activity

Recently reported changes by institutional investors

Insider Trading

Quarterly net insider trading by ABUS's directors and management

Corporate Lobbying

Government lobbying spending instances

Quiver Logo

No Corporate Lobbying instances for this ticker

Corporate Lobbying Dashboard
Corporate Lobbying

Estimated quarterly lobbying spending

Quiver Logo

No Corporate Lobbying data for this ticker

Corporate Lobbying Dashboard
U.S. Patents

New patents grants

  • Patent Title: Non-liposomal systems for nucleic acid delivery Oct. 29, 2024
  • Patent Title: Substituted 1,1′-biphenyl compounds, analogues thereof, and methods using same Sep. 10, 2024
  • Patent Title: Targeted compositions Jul. 23, 2024
  • Patent Title: Lipids and compositions for the delivery of therapeutics Jul. 23, 2024
  • Patent Title: Non-liposomal systems for nucleic acid delivery Jul. 16, 2024
  • Patent Title: Lipid compositions Jul. 02, 2024
  • Patent Title: Lipid formulations for delivery of therapeutic agents Jun. 25, 2024
  • Patent Title: Methods for ameliorating infusion reactions Feb. 20, 2024
  • Patent Title: Targeted nucleic acid conjugate compositions Feb. 13, 2024
  • Patent Title: Lipid formulations for delivery of therapeutic agents Oct. 17, 2023
  • Patent Title: Non-liposomal systems for nucleic acid delivery Aug. 08, 2023
  • Patent Title: Lipids and compositions for the delivery of therapeutics Aug. 01, 2023
  • Patent Title: Substituted 2-pyridone tricyclic compounds, analogues thereof, and methods using same Jul. 18, 2023
  • Patent Title: Substituted tetrahydrocyclopenta[c]pyrroles, substituted dihydropyrrolizines, analogues thereof, and methods using same Jan. 31, 2023
  • Patent Title: Methods for preparing substituted pyridinone-containing tricyclic compounds Nov. 22, 2022
  • Patent Title: Lipid formulations for delivery of therapeutic agents Sep. 20, 2022
  • Patent Title: Targeted compositions Aug. 30, 2022
  • Patent Title: Lipid containing formulations Aug. 23, 2022
  • Patent Title: Trialkyl cationic lipids and methods of use thereof Jul. 26, 2022
  • Patent Title: Methods for ameliorating infusion reactions Jun. 07, 2022
  • Patent Title: Liposomal apparatus and manufacturing methods May. 03, 2022
  • Patent Title: Liposomal apparatus and manufacturing methods Apr. 12, 2022
  • Patent Title: Compositions and methods for delivering messenger rna Dec. 07, 2021
  • Patent Title: Lipid formulations for nucleic acid delivery Oct. 12, 2021
  • Patent Title: Substituted 2,3-dihydro-1h-indene analogs and methods using same Sep. 28, 2021
  • Patent Title: Substituted dihydroindene-4-carboxamides and analogs thereof, and methods using same Aug. 24, 2021
  • Patent Title: Lipids and compositions for the delivery of therapeutics Aug. 03, 2021
  • Patent Title: Substituted pyridinone-containing trycyclic compounds, and methods using same May. 25, 2021
  • Patent Title: Substituted chromane-8-carboxamide compounds and analogues thereof, and methods using same May. 11, 2021
  • Patent Title: Lipid compositions Mar. 23, 2021
  • Patent Title: Lipids and compositions for the delivery of therapeutics Nov. 17, 2020
  • Patent Title: Lipids and compositions for the delivery of therapeutics Nov. 03, 2020
  • Patent Title: Substituted pyridinone-containing trycyclic compounds, and methods using same Nov. 03, 2020
  • Patent Title: Trialkyl cationic lipids and methods of use thereof Feb. 18, 2020
  • Patent Title: Substituted 1-hydroxy-pyridin-2(1h)-ones, and methods of making and using same Feb. 04, 2020
  • Patent Title: Lipid compositions Oct. 29, 2019
  • Patent Title: Compositions and methods for silencing hepatitis b virus gene expression Sep. 17, 2019
  • Patent Title: Substituted 2-n-hydroxy-1,3-dioxo-1,2,3,4-tetrahydronaphthyridines, and methods of making and using same Jul. 23, 2019
  • Patent Title: Lipids and compositions for the delivery of therapeutics Nov. 06, 2018
  • Patent Title: Cyclic cationic lipids and methods of use Sep. 18, 2018
  • Patent Title: Methods for increasing efficacy of lipid formulated sirna Aug. 21, 2018
  • Patent Title: Site-specific delivery of nucleic acids by combining targeting ligands with endosomolytic components Feb. 20, 2018
  • Patent Title: Targeting lipids Nov. 14, 2017
  • Patent Title: Lipids and compositions for the delivery of therapeutics Sep. 19, 2017
  • Patent Title: Lipids and compositions for the delivery of therapeutics Jul. 18, 2017
  • Patent Title: Lipid compositions Jul. 04, 2017
  • Patent Title: Compositions for nucleic acid delivery Jun. 27, 2017
  • Patent Title: Lipids and compositions for the delivery of therapeutics Jun. 20, 2017
  • Patent Title: Lipid containing formulations May. 30, 2017
  • Patent Title: In vitro release assay for liposome encapsulated vincristine May. 02, 2017
Government Contracts

Federal grants, loans, and purchases

Quiver Logo

No Government Contracts for this ticker

Government Contracts Dashboard
Government Contracts

Estimated quarterly amount awarded from public contracts

Quiver Logo

No recent Government Contracts for this ticker

Government Contracts Dashboard
WallStreetBets

Number of mentions of ABUS in WallStreetBets Daily Discussion

ABUS News

Recent insights relating to ABUS

CNBC Recommendations

Recent picks made for ABUS stock on CNBC

Top ETF Holders

ETFs with the largest estimated holdings in ABUS

ABUS Stock Smart Score

The Quiver Smart Score combines our data on Congress Trading, Lobbying, Insider Trading, CNBC Mentions and more to provide a comprehensive view of the strength of a stock's underlying data.

The Smart Score grades stocks on a scale of 1 (weakest) to 10 (strongest) based on the strength of the underlying data.
?

Sign Up to view ABUS Smart Score

Score Breakdown
Bull Case vs Bear Case

See concise summaries of analyst reports, presenting both bullish and bearish arguments for a stock.

Example:

Bulls Say:

The Bulls Say summary highlights positive aspects of the stock.

Bears Say:

The Bears Say summary points out potential risks and negative aspects of the stock.

Show More
Back To Top